Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Laminin receptor 1 (LAMR1), also known as the 37/67-kDa laminin receptor or Ribosomal Protein SA (RPSA), is a multifunctional protein that serves as a primary cell-surface receptor for Adeno-associated virus serotype 8 (AAV8) (Akache et al., 2006). While it functions intracellularly as a component of the 40S ribosomal subunit, its expression on the plasma membrane of hepatocytes is a critical determinant of the high liver tropism and transduction efficiency exhibited by AAV8-based gene therapies (UniProt P08865). AAV8 capsids bind to the extracellular domain of LAMR1 to facilitate viral attachment and subsequent internalization via receptor-mediated endocytosis (Zincarelli et al., 2008). In addition to LAMR1, the universal Adeno-associated virus receptor (AAVR, also known as KIAA0319L) is required for the post-attachment trafficking of AAV8 within the cell (Pillay et al., 2016). LAMR1's involvement in cell-matrix adhesion and its frequent overexpression in various cancers make it a significant factor in both viral vector design and oncology (Nelson et al., 2008). Understanding the interaction between AAV8 and LAMR1 is essential for optimizing liver-directed gene transfer and managing the safety profile of therapies for conditions like hemophilia and metabolic disorders (Wang et al., 2010).
Mediates viral attachment to the hepatocyte surface and facilitates cellular entry via receptor-mediated endocytosis
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Laminin receptor 1 (LAMR1) (LAMR1).